Biomerica (BMRA) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -243.00 |
| Nov 30, 2025 | -1,828.00 |
| Aug 31, 2025 | 2,040.00 |
| May 31, 2025 | -5,790.00 |
| Feb 28, 2025 | -1,631.00 |
| Nov 30, 2024 | -266.00 |
| Aug 31, 2024 | -1,476.00 |
| May 31, 2024 | -1,372.00 |
| Feb 29, 2024 | -4,367.00 |
| Nov 30, 2023 | -645.00 |
| Aug 31, 2023 | -244.00 |
| May 31, 2023 | -2,111.00 |
| Feb 28, 2023 | -2,303.00 |
| Nov 30, 2022 | -762.00 |
| Aug 31, 2022 | -3,898.00 |
| May 31, 2022 | -1,856.00 |
| Feb 28, 2022 | -812.00 |
| Nov 30, 2021 | -2,226.00 |
| Aug 31, 2021 | -4,797.00 |
| May 31, 2021 | -2,487.00 |
| Feb 28, 2021 | -2,733.00 |
| Nov 30, 2020 | -1,287.00 |
| Aug 31, 2020 | -2,242.00 |
| May 31, 2020 | -584.00 |
| Feb 29, 2020 | -1,730.00 |
| Nov 30, 2019 | 227.00 |
| Aug 31, 2019 | 79.00 |
| May 31, 2019 | -1,872.00 |
| Feb 28, 2019 | -974.00 |
| Nov 30, 2018 | -16.00 |
| Aug 31, 2018 | 82.00 |
| May 31, 2018 | -898.00 |
| Feb 28, 2018 | 239.00 |
| Nov 30, 2017 | -946.00 |
| Aug 31, 2017 | -740.00 |
| May 31, 2017 | -517.00 |
| Feb 28, 2017 | -746.00 |
| Nov 30, 2016 | -242.00 |
| Aug 31, 2016 | 423.00 |
| May 31, 2016 | -163.00 |
| Feb 29, 2016 | -1,181.00 |
| Nov 30, 2015 | 948.00 |